The Medical Science Liaison (MSL) serves as the primary medical contact for External Experts, engaging them in scientific discussions and projects to maximize the potential of Boehringer Ingelheim medications. These activities align with the agreed strategy and compliance regulations, balancing customer-facing and back-office responsibilities.
At Boehringer Ingelheim, we create value through innovation with one clear goal in mind: to improve the quality of life for our patients. We develop breakthrough therapies and innovative solutions in healthcare, addressing the medical needs of both humans and animals. As a family-owned company, we focus on long-term results. We employ 52,000 people worldwide who foster a diverse, collaborative, and unifying culture. Science and knowledge are key to us – because the growth of each individual contributes to the growth of the entire organization.